HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The prophylaxis and treatment with antiviral agents of respiratory syncytial virus infections.

Abstract
In this review, we consider recent advances in the discovery and development of antiviral agents for respiratory syncytial virus (RSV) infections. A background to the various manifestations of human RSV infection and current treatments is provided. The technical, clinical and commercial issues surrounding the development of such antiviral agents are discussed.
AuthorsPilar Najarro, Richard Angell, Kenneth Powell
JournalAntiviral chemistry & chemotherapy (Antivir Chem Chemother) Vol. 22 Issue 4 Pg. 139-50 (Jan 17 2012) ISSN: 2040-2066 [Electronic] England
PMID22182737 (Publication Type: Journal Article, Review)
Copyright© 2012 International Medical Press
Chemical References
  • Antiviral Agents
Topics
  • Antiviral Agents (therapeutic use)
  • Biomedical Research
  • Drug Discovery (economics, methods)
  • Drug Industry (economics)
  • Humans
  • Models, Biological
  • Respiratory Syncytial Virus Infections (drug therapy, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: